Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery

Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery ID - 453062 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453062/all/Effect_of_pexelizumab_on_mortality_in_patients_with_acute_myocardial_infarction_or_undergoing_coronary_artery_bypass_surgery PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -